A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder.

Saved in:
Bibliographic Details
Title: A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder.
Authors: Shin JH; Department of Urology, Ewha Womans University Mokdong Hospital, Seoul, Korea., Jeong SJ; Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea., Kim SO; Department of Urology, Chonnam National University Medical School, Gwangju, Korea., Oh CY; Department of Urology, Hallym University Sacred Heart Hospital, Anyang, Korea., Chung KJ; Department of Urology, Gachon University Gil Medical Center, Incheon, Korea., Shin DG; Department of Urology, Pusan Nation University School of Medicine, Busan, Korea., Kim TH; Department of Urology, Dong-A University College of Medicine, Busan, Korea., Kwon J; Department of Urology, Daegu Fatima Hospital, Daegu, Korea., Shin JH; Department of Urology, College of Medicine, Chungnam National University, Daejeon, Korea., Bae WJ; Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea., Lee KS; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Choo MS; Department of Urology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.
Source: International neurourology journal [Int Neurourol J] 2023 Jun; Vol. 27 (2), pp. 106-115. Date of Electronic Publication: 2023 Jun 30.
Publication Type: Journal Article
Journal Info: Publisher: Korean Continence Society Country of Publication: Korea (South) NLM ID: 101534513 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2093-4777 (Print) Linking ISSN: 20934777 NLM ISO Abbreviation: Int Neurourol J Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2093-4777
DOI:10.5213/inj.2346022.011